Statements (42)
Predicate | Object |
---|---|
gptkbp:instanceOf |
vitamin D metabolite
secosteroid hormone |
gptkbp:approvedDrugIn |
gptkb:United_States
|
gptkbp:ATCCode |
A11CC04
|
gptkbp:biosynthesized_from |
gptkb:vitamin_A
gptkb:kidney |
gptkbp:CASNumber |
32222-06-3
|
gptkbp:category |
hormone
vitamin D metabolite secosteroid |
gptkbp:chemicalFormula |
C27H44O3
|
gptkbp:deactivatedIn |
gptkb:kidney
liver |
gptkbp:deactivationEnzyme |
24-hydroxylase
|
gptkbp:discoveredBy |
Anthony W. Norman
Hector DeLuca |
gptkbp:firstDescribed |
1971
|
gptkbp:function |
regulation of phosphate homeostasis
modulation of immune system regulation of calcium homeostasis bone mineralization promotion of intestinal calcium absorption |
https://www.w3.org/2000/01/rdf-schema#label |
1,25-dihydroxyvitamin D3
|
gptkbp:IUPACName |
(1R,3S,5Z,7E,22E)-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,25-triol
|
gptkbp:meltingPoint |
120-125°C
|
gptkbp:molecularWeight |
416.64 g/mol
|
gptkbp:otherName |
gptkb:calcitriol
|
gptkbp:predecessor |
gptkb:25-hydroxyvitamin_D3
|
gptkbp:PubChem_CID |
5280453
CHEMBL1204 |
gptkbp:recipient |
vitamin D receptor
|
gptkbp:routeOfAdministration |
oral
intravenous |
gptkbp:solubility |
insoluble in water
soluble in ethanol soluble in chloroform |
gptkbp:UNII |
FXC9231JVH
|
gptkbp:usedFor |
gptkb:secondary_hyperparathyroidism
hypocalcemia renal osteodystrophy |
gptkbp:bfsParent |
gptkb:25-hydroxyvitamin_D3
|
gptkbp:bfsLayer |
6
|